False-negative scans may be observed in approximately 10% of neuroblastomas that do not concentrate mIBG, owing to low expression of the norepinephrine transporter (Carlin et al, 2003), or owing to blood–brain barrier or large areas of scar or necrosis (Matthay et al, 2003a). Here, SLC6A2 is linked to neuroblastoma.